USMLE STEP 1 • MICROBIOLOGY

Viral Structure And Replication

Understanding how obligate intracellular parasites assemble and hijack host machinery to propagate infectious progeny.

Historical Context & Discovery of Viruses

The concept of a submicroscopic infectious agent smaller than bacteria fundamentally reshaped our understanding of disease. In the late nineteenth century, researchers observed that certain diseases could be transmitted by filtrates that passed through porcelain filters designed to trap all known bacteria. This filterable agent—eventually termed a virus from the Latin word for poison—challenged the prevailing germ theory and opened an entirely new chapter in microbiology. Understanding viral structure became essential once it was recognized that these agents cause diseases ranging from rabies and smallpox to influenza and HIV, each exploiting host cells in remarkably specific ways.

1892
Ivanovsky's Filterable Agent
Dmitri Ivanovsky demonstrated that the causative agent of tobacco mosaic disease passed through Chamberland filters, providing the first evidence of an infectious particle smaller than bacteria.
1935
Crystallization of TMV
Wendell Stanley crystallized tobacco mosaic virus (TMV), proving viruses had a defined molecular structure—a landmark that earned him the Nobel Prize and opened viruses to biochemical analysis.
1952
Hershey–Chase Experiment
Using radiolabeled bacteriophages, Alfred Hershey and Martha Chase confirmed that DNA, not protein, is the genetic material injected into host cells—solidifying the concept of viral nucleic acid as the replicative core.
1962
Caspar & Klug Icosahedral Theory
Donald Caspar and Aaron Klug proposed the quasi-equivalence theory of icosahedral capsid assembly, explaining how a limited viral genome could encode a large, symmetric protein shell using repeating subunits.
1983
Discovery of HIV
Luc Montagnier and Françoise Barré-Sinoussi identified HIV as a retrovirus, highlighting the clinical importance of understanding viral structure for developing antiretrovirals targeting reverse transcriptase and protease.

These milestones collectively raised a fundamental question that remains central to medical virology today: how does the structural organization of a virus dictate its replication strategy, host tropism, and pathogenesis? Answering this question is critical for developing targeted antiviral therapies and vaccines—topics that appear frequently on the USMLE Step 1.

Core Principles of Viral Architecture

All viruses share certain architectural features despite enormous diversity in size, genome type, and replication strategy. A virus particle, or virion, is an extracellular form optimized for transmitting viral nucleic acid from one host cell to another. The virion is metabolically inert; it contains no ribosomes, no energy-generating systems, and no functional translational apparatus. These features classify viruses as obligate intracellular parasites that depend entirely on host cell machinery for replication. The structural components of a virion determine how it attaches to target cells, evades the immune system, and delivers its genome for replication.

1

Nucleic Acid Core (Genome)

The viral genome can be DNA or RNA, single-stranded (ss) or double-stranded (ds), linear or circular, and segmented or non-segmented. This nucleic acid type dictates the replication strategy according to the Baltimore classification.
2

Capsid

A protein shell composed of repeating subunits called capsomeres protects the genome. Capsid symmetry is either icosahedral (20 triangular faces), helical (rod-shaped), or complex. Capsid proteins are encoded by the viral genome.
3

Envelope

Some viruses acquire a lipid bilayer envelope derived from the host cell membrane during budding. Embedded glycoproteins mediate attachment and entry. Enveloped viruses are susceptible to detergents, desiccation, and heat.
4

Viral Enzymes

Certain viruses carry essential enzymes within the virion—e.g., RNA-dependent RNA polymerase in negative-sense RNA viruses and reverse transcriptase in retroviruses—because host cells lack these activities.
5

Matrix Proteins

In enveloped viruses, matrix (M) proteins form a layer between the capsid (nucleocapsid) and the lipid envelope, providing structural integrity and facilitating virion assembly during budding.
KEY TAKEAWAY
Think of a virion like a USB flash drive: it carries genetic 'software' (the nucleic acid) inside a protective 'casing' (the capsid), and sometimes wrapped in an additional 'sleeve' (the envelope). The USB drive has no processor or power supply of its own—it only functions when plugged into a computer (the host cell). Similarly, a virus must commandeer the host's ribosomes, ATP, and nucleotides to execute its genetic program.

Visual Overview of Viral Architecture

Left: An enveloped virus (e.g., influenza, HIV) features a host-derived lipid bilayer studded with viral glycoprotein spikes. Matrix proteins line the inner envelope surface. Right: A naked (non-enveloped) virus (e.g., adenovirus, norovirus) consists of an icosahedral capsid directly enclosing the genome. Naked viruses are environmentally hardier because they lack a fragile lipid membrane.

The diagram above highlights the critical structural distinction tested on USMLE Step 1: enveloped viruses acquire their lipid bilayer from host membranes during budding, making them susceptible to detergents, alcohol-based disinfectants, and desiccation. In contrast, naked (non-enveloped) viruses are stable in harsh environments, resist drying, and can survive on fomites for extended periods—this is why norovirus and hepatitis A virus spread readily via the fecal-oral route. The glycoprotein spikes on enveloped viruses serve as the primary targets for neutralizing antibodies and determine viral tropism by binding specific host cell receptors, such as the interaction between HIV gp120 and CD4.

The Viral Replication Cycle

Viral replication follows a conserved sequence of events regardless of the specific virus, although each step can vary dramatically in its molecular details. The general scheme is often summarized as: attachment → penetration → uncoating → genome replication and gene expression → assembly → release. Understanding each step is essential because antiviral drugs are designed to target specific phases—for example, oseltamivir (Tamiflu) inhibits neuraminidase to block release of influenza virions.

Step-by-Step Replication Mechanism

  1. 1. Attachment (Adsorption): Viral surface proteins (e.g., hemagglutinin on influenza, gp120/gp41 on HIV) bind specific host cell receptors. This interaction determines viral tropism—which cell types and species a virus can infect.
  2. 2. Penetration (Entry): Enveloped viruses may fuse directly with the plasma membrane (e.g., HIV) or undergo receptor-mediated endocytosis followed by fusion with the endosomal membrane (e.g., influenza). Naked viruses typically enter by endocytosis or direct translocation of the genome.
  3. 3. Uncoating: The capsid is disassembled, releasing the viral genome into the cytoplasm or, for DNA viruses that replicate in the nucleus (except poxviruses), into the nucleus. Amantadine historically blocked influenza A uncoating by inhibiting the M2 ion channel.
  4. 4. Replication & Gene Expression: The virus commandeers host ribosomes to translate viral mRNA into proteins, while the genome is replicated by viral or host polymerases. The Baltimore classification determines the pathway from genome to mRNA.
  5. 5. Assembly: Newly synthesized structural proteins and replicated genomes are assembled into progeny virions in the cytoplasm or nucleus, depending on the virus family.
  6. 6. Release: Enveloped viruses typically exit by budding through the host membrane, acquiring their lipid envelope in the process. Naked viruses generally lyse the cell to release progeny. Influenza neuraminidase cleaves sialic acid residues to free budding virions from the cell surface.
The generalized viral replication cycle within a host cell: ① Attachment of viral surface proteins to host receptors, ② Penetration via fusion or endocytosis, ③ Uncoating to release the genome, ④ Replication of nucleic acid and translation of viral proteins, ⑤ Assembly of new virions, and ⑥ Release by budding (enveloped) or lysis (naked). Each numbered step is a potential target for antiviral therapy.
💊 CLINICAL PEARL
Antiviral drug targets map directly to replication steps: enfuvirtide blocks HIV fusion (penetration), acyclovir inhibits viral DNA polymerase (replication), and oseltamivir inhibits neuraminidase (release). Knowing the replication cycle lets you predict which step each drug class targets—a high-yield USMLE concept.

Baltimore Classification & Genome Strategies

The Baltimore classification, devised by Nobel laureate David Baltimore in 1971, categorizes viruses into seven classes based on their genome type and the pathway used to produce mRNA. This system is the cornerstone of medical virology because it predicts which enzymes a virus must carry, how its genome is replicated, and which antiviral strategies may be effective. The central principle is that all viruses must produce positive-sense mRNA that can be read by host ribosomes—the route to that mRNA defines the class.

Baltimore Classification of Viruses — the definitive framework for understanding genome-to-mRNA strategies.
Baltimore ClassGenome TypePathway to mRNAKey ExamplesPackaged Enzyme?
IdsDNAdsDNA → mRNA (host RNA pol)Herpes, Adenovirus, HPVNo (except Poxvirus—own RNA pol)
IIssDNAssDNA → dsDNA → mRNAParvovirus B19No
IIIdsRNAdsRNA → mRNA (viral RdRp)Reovirus (Rotavirus)Yes — RNA-dependent RNA polymerase
IV(+) ssRNAGenome IS the mRNAPicornavirus, Flavivirus, CoronavirusNo (genome directly translated)
V(−) ssRNA(−) ssRNA → mRNA (viral RdRp)Influenza, Ebola, RabiesYes — RNA-dependent RNA polymerase
VI(+) ssRNA (retrovirus)ssRNA → dsDNA → mRNAHIV, HTLVYes — Reverse transcriptase, Integrase
VIIdsDNA (with RT step)dsDNA → RNA → dsDNA → mRNAHepatitis B (Hepadnavirus)Yes — Reverse transcriptase
HIGH-YIELD RULE
Negative-sense ssRNA viruses (Class V) and dsRNA viruses (Class III) must carry their own RNA-dependent RNA polymerase (RdRp) in the virion because the host cell has no enzyme capable of synthesizing mRNA from an RNA template. Positive-sense ssRNA viruses (Class IV) do not need to carry polymerase because their genome can be directly translated upon entry—like handing a pre-written recipe to the kitchen.
KEY TAKEAWAY
The Baltimore classification is like a postal sorting system: every package (genome) must eventually be converted into a standardized format (positive-sense mRNA) before it can be 'delivered' (translated by ribosomes). Some packages arrive ready to deliver (Class IV, positive-sense RNA), while others need reformatting—either by the virus's own machinery (Classes III, V, VI, VII) or by host enzymes (Classes I, II). Knowing what reformatting is needed tells you what enzymes the virus must bring along.

Worked Example: Tracing HIV Replication

Let us trace the complete replication cycle of HIV (Human Immunodeficiency Virus)—a Baltimore Class VI retrovirus—from initial attachment to release of progeny virions. This example integrates structural knowledge, Baltimore classification, and pharmacology, making it a prototypical USMLE vignette.

HIV Replication Cycle — Step-by-Step
1
Step 1 — AttachmentThe HIV envelope glycoprotein gp120 binds the CD4 receptor on helper T cells (and macrophages/dendritic cells). A conformational change then allows gp120 to bind a coreceptor—either CCR5 (macrophage-tropic, R5 strains) or CXCR4 (T-cell-tropic, X4 strains). Maraviroc is a CCR5 antagonist that blocks this step.
gp120 binds CD4 + coreceptor (CCR5 or CXCR4)
2
Step 2 — Fusion & PenetrationCoreceptor binding triggers gp41 to undergo a conformational change, inserting its fusion peptide into the host membrane and mediating direct membrane fusion. The viral nucleocapsid is released into the cytoplasm. Enfuvirtide (T-20) is a fusion inhibitor that blocks gp41-mediated membrane fusion.
gp41 mediates membrane fusion → nucleocapsid enters cytoplasm
3
Step 3 — Reverse TranscriptionInside the cytoplasm, HIV's reverse transcriptase (RT) converts the (+) ssRNA genome into double-stranded DNA (dsDNA) via an RNA→DNA→dsDNA sequence. RT has three enzymatic activities: RNA-dependent DNA polymerase, RNase H (degrades the RNA template), and DNA-dependent DNA polymerase. NRTIs (e.g., tenofovir, emtricitabine) and NNRTIs (e.g., efavirenz) inhibit RT.
(+) ssRNA → dsDNA provirus via reverse transcriptase
4
Step 4 — IntegrationThe viral dsDNA (provirus) is transported to the nucleus where integrase inserts it into the host chromosome. Once integrated, the provirus is replicated along with host DNA during cell division, establishing a latent reservoir that is extremely difficult to eradicate. Integrase strand transfer inhibitors (INSTIs) like dolutegravir and raltegravir block this step.
Integrase inserts proviral dsDNA into host genome → latent reservoir
5
Step 5 — Transcription, Translation & AssemblyHost RNA polymerase II transcribes the proviral DNA into mRNA and full-length genomic RNA. Viral mRNAs are translated on host ribosomes into structural polyproteins (Gag, Gag-Pol) and envelope glycoproteins (gp160, which is cleaved to gp120/gp41). Immature virions bud through the plasma membrane, acquiring the lipid envelope.
Proviral DNA → mRNA → polyproteins → immature virion buds from membrane
6
Step 6 — Maturation & ReleaseAfter budding, HIV protease cleaves the Gag and Gag-Pol polyproteins into functional capsid (p24), matrix (p17), and enzymatic components. This maturation step converts the immature, non-infectious particle into an infectious virion. Protease inhibitors (e.g., ritonavir, darunavir) prevent this cleavage, producing non-infectious particles.
Protease cleaves polyproteins → mature, infectious HIV virion

Enveloped vs. Naked Viruses — Clinical Implications

The presence or absence of a lipid envelope has profound consequences for viral transmission, environmental stability, and susceptibility to disinfection. This distinction appears repeatedly in USMLE vignettes, particularly in questions about infection control, modes of transmission, and laboratory diagnostics.

Clinical comparison of enveloped and naked virus properties — a frequent USMLE topic.
PropertyEnveloped VirusesNaked (Non-Enveloped) Viruses
Environmental stabilityFragile — quickly inactivated by desiccation, heat, detergents, and acidHardy — stable on fomites, resist drying, acid-stable (survive GI tract)
Transmission routeRequires close contact: respiratory droplets, blood, sexual contact, verticalFecal-oral, fomites, respiratory — can survive outside the body
DisinfectionEasily killed by alcohol-based sanitizers and detergentsResistant to alcohol and detergents; require bleach or autoclaving
Release mechanismBudding — typically does not immediately lyse the cellCell lysis — host cell is destroyed to release progeny
Immune targetEnvelope glycoproteins (primary targets for neutralizing antibodies)Capsid proteins (targets for antibody neutralization)
ExamplesHIV, Influenza, HBV, HCV, Ebola, HSV, RSV, CoronavirusNorovirus, Rotavirus, Adenovirus, HPV, Poliovirus, HAV, Parvovirus B19
KEY TAKEAWAY
Remember that naked viruses are the environmental 'survivors'—they persist on surfaces, resist hand sanitizer, and thrive in the fecal-oral route (think norovirus outbreaks on cruise ships). A helpful mnemonic: "Naked is tough"—without a fragile lipid coat, these viruses can withstand conditions that would destroy enveloped counterparts. If a question describes a pathogen causing gastroenteritis that is resistant to alcohol-based hand sanitizers, think naked virus.

Viral Genetics — Mutation, Reassortment & Recombination

The replication strategies described above also determine how viruses evolve and generate genetic diversity—concepts with direct clinical significance for vaccine design and emerging pandemics. Two major mechanisms of viral genetic change are commonly tested on USMLE Step 1: antigenic drift and antigenic shift. Understanding these requires knowledge of viral replication fidelity and genome segmentation.

Antigenic drift vs. antigenic shift — critical for understanding influenza epidemiology.
FeatureAntigenic DriftAntigenic Shift
MechanismPoint mutations accumulate in surface antigen genes (HA, NA) during replication by error-prone RNA polymeraseReassortment of genome segments when two different influenza strains co-infect the same cell (requires segmented genome)
Degree of changeMinor, gradual — small antigenic changes over timeMajor, abrupt — entirely new surface antigen combinations
Clinical consequenceSeasonal epidemics — necessitates annual flu vaccine reformulationPandemics — population lacks pre-existing immunity to novel strain
Viruses involvedAll RNA viruses (especially influenza A and B)Only influenza A (segmented genome + animal reservoirs)
AnalogySlowly changing your appearance with minor wardrobe tweaksPutting on a completely different disguise — unrecognizable

Beyond drift and shift, other forms of viral genetic variation include recombination (exchange of genetic material between co-infecting non-segmented viruses, as occurs with coronaviruses and retroviruses), complementation (one virus provides a functional protein that another defective virus lacks, allowing both to replicate), and phenotypic mixing (a virion packages its genome inside the capsid or envelope proteins of a co-infecting virus, temporarily altering host range without genetic change). These advanced concepts bridge basic virology to emerging infectious disease research and are occasionally tested in clinical vignettes.

Practice Problems

PROBLEM 1CONCEPTUAL
A virology student isolates a virus with a negative-sense single-stranded RNA genome. She notes that purified genomic RNA alone is NOT infectious when introduced into host cells. Why must this virus carry its own RNA-dependent RNA polymerase (RdRp) within the virion?
PROBLEM 2BASIC CALCULATION
A single HIV-infected CD4⁺ T cell produces approximately 10³ new virions per replication cycle. If HIV reverse transcriptase has an error rate of approximately 1 mutation per 10⁴ nucleotides and the HIV genome is approximately 9.7 × 10³ nucleotides, estimate the average number of mutations introduced per newly synthesized proviral genome.
PROBLEM 3INTERMEDIATE
A 4-year-old boy in a daycare presents with vomiting and watery diarrhea. Several other children are also ill. The pathogen is determined to be resistant to alcohol-based hand sanitizers. Stool electron microscopy reveals a non-enveloped, double-shelled icosahedral virus. Which Baltimore class does this virus belong to, and what enzyme must it package in the virion? Explain why the virus resists alcohol-based sanitizers.
PROBLEM 4APPLIED
A 32-year-old man with newly diagnosed HIV begins antiretroviral therapy with tenofovir/emtricitabine (NRTIs), dolutegravir (INSTI), and a pharmacokinetic booster. For each drug class in this regimen, identify the specific step of the HIV replication cycle that is inhibited. Then explain why a protease inhibitor was not included as the primary backbone and describe the step it would target if added.
PROBLEM 5CRITICAL THINKING
Influenza A virus undergoes both antigenic drift and antigenic shift, whereas influenza C virus undergoes drift but not shift. Explain the structural and genetic basis for this difference. Additionally, predict why a universal influenza vaccine is difficult to develop, integrating your understanding of viral structure and replication fidelity.

Viral Structure & Replication — Summary

Viruses are obligate intracellular parasites composed of a nucleic acid core (DNA or RNA, ss or ds) enclosed in a protective capsid, and sometimes surrounded by a host-derived lipid envelope bearing glycoprotein spikes that mediate attachment. The Baltimore classification groups viruses into seven classes based on genome type and the pathway to mRNA, predicting which enzymes must be packaged (e.g., RdRp for negative-sense and dsRNA viruses, reverse transcriptase for retroviruses and hepadnaviruses).

The replication cycle—attachment, penetration, uncoating, replication/expression, assembly, and release—provides the framework for understanding antiviral pharmacology. Enveloped viruses are fragile and spread by close contact, while naked viruses are environmentally hardy and often spread fecal-orally. Viral genetic variation through antigenic drift (point mutations) and antigenic shift (reassortment of segmented genomes) explains seasonal epidemics and pandemics, respectively. Mastering these structural and replicative principles enables you to predict viral behavior, anticipate drug targets, and answer USMLE questions with mechanistic reasoning.

Varsity Tutors • USMLE Step 1 • Viral Structure And Replication